Tanisha Terry
Women's Health · Houston, TXNPI 1760242903
Payments from drug & device makers
Across 51 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$210
- Daiichi Sankyo Inc.$207
- Astellas Pharma US Inc$153
- Exeltis, USA Inc.$101
- Sumitomo Pharma America, Inc.$96
- Organon$40
- plus $292 from 13 others
What the payments were for
- Food & beverage$1,08999%
- Entertainment$101%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 1 | $210 |
| Daiichi Sankyo Inc. | 9 | $207 |
| Astellas Pharma US Inc | 9 | $153 |
| Exeltis, USA Inc. | 5 | $101 |
| Sumitomo Pharma America, Inc. | 6 | $96 |
| Organon | 3 | $40 |
| Sage Therapeutics, LLC | 2 | $32 |
| Mayne Pharma Commercial LLC | 2 | $32 |
| Exact Sciences | 2 | $30 |
| Baxter Healthcare | 1 | $27 |
| Evofem Biosciences, Inc. | 3 | $24 |
| Medtronic | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Bayer | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $20 |
| Millicent US Inc | 1 | $14 |
| Amgen | 1 | $13 |
| Argentum Medical | 1 | $10 |
How this compares
$1,100 in reported general payments places this provider in the 75th percentile of 609 women's health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 11 | $179 |
Paid to pharmacies, not to this prescriber.
Other women's health in Houston
- Joann St PierreHouston$15K
- Lori WinkHouston$9K
- Andrea DunnHouston$6K
- Kim GustafsonHouston$4K
- Erica SmithHouston$4K
- Christie LouisHouston$3K
- Mary UmbleHouston$3K
- Kim OkewunmiHouston$3K
- Kathryn AckermanHouston$2K
- Evelyn TingGrapevine$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.